21. 10月 2019 - 8:00
それを共有します:

World Congress on Advances in Brain Injury, Disorders and Therapeutics (CSE) | | 月曜日, 21. 10月 2019

World Congress on Advances in Brain Injury, Disorders and Therapeutics
About ConferenceThe World Congress on Advances in Brain injury, Disorders and Therapeutics would be stage for interconnecting National and Global specialists, scientists and chiefs both from the scholarly world and industry from everywhere throughout the world to trade their insight, skill and research developments in the field of Brain issue, Neurology and Therapeutics. These Brain Issue and Neurology meeting is a station for trading thought and learning on Cerebrum damage, brain tumour, brain Issue, Neurology, Neuroscience, Neuroimaging and Neurological issue. This conference includes the investigation identified with the conclusion and treatment of infection or failing of the cerebrum, muscles, fringe nerves, spinal cord and autonomic sensory system. The target of gathering is to keep up and create science and related research at a universal level. To accomplish this, it is vital to carry into significant field of neurology with the novel investigations, which can spare a huge number of lives w Navigating the Future Advancements in Brain TherapeuticsScientific SessionsTrack 1:Brain InjuryA Brain injury is any sort of injury to your brain, skull, or scalp. This can range from a mild bump or bruise to a traumatic brain injury. Common head injuries include concussions, skull fractures, and scalp wounds. The consequences and treatments vary greatly, depending on what caused your head injury and how severe it is. Brain injuries may be either closed or open. A closed head injury is any injury that doesn’t break your skull. An open (penetrating) head injury is one in which something breaks your scalp and skull and enters your brain. It can be hard to assess how serious a head injury is just by looking. Some minor head injuries bleed a lot, while some major injuries don’t bleed at allTrack 2:Brain Disorders and PathophysiologyA neurological issue is any disorder of the sensory system. Auxiliary, biochemical or electrical variations from the norm in the mind, spinal line or different nerves can bring about a scope of manifestations. Cases of side effects incorporate loss of motion, muscle shortcoming, poor coordination, loss of sensation, seizures, perplexity, torment and modified levels of awareness. There are numerous perceived neurological issue, some moderately normal, however numerous uncommon. They might be evaluated by neurological examination and contemplated and treated inside the specialities of neurology and clinical neuropsychologyTrack 3:Brain ComplicationA Brain Injury is any injury that results in trauma to the skull or brain. The terms traumatic brain injury and head injury are often used interchangeably in the medical literature. This broad classification includes neuronal injuries, haemorrhages, vascular injuries, cranial nerve injuries, and subdural hygromas, among many others. These classifications can be further categorized as open (penetrating) or closed head injuriesTrack 4:Traumatic Brain InjuryTraumatic brain injury is a degenerative or congenital nature, but caused by external physical force that may produce a diminished or altered state of consciousness, which results in an impairment of cognitive abilities or physical functioning.The disturbances of cognitive, emotional, and behaviour functioning after TBI may produce permanent are 3 different types of traumatic brain injury are folowing Mild traumatic brain injury is a trauma to the head that results in a confused state or a loss of consciousness of less than 30 minutes. Moderate traumatic brain injury is a trauma to the head that results in a loss of consciousness of 30 minutes to 24 hours. Severe traumatic brain injury is a trauma to the head that results in a loss of consciousness of greater than 24 hoursTrack 5:Brain Injury BiomarkersBrain Injury is usually reliably visible as structural abnormalities using techniques such as computed tomography (CT) or conventional magnetic resonance imaging (MRI), more subtle disturbances characteristic of mild TBI are not so easily demonstrated by these imaging modalities. Mild TBI results from the main etiologist of neural contusion and axonal injury, which subsequently results in biochemical, metabolic, and cellular changes that may be responsible for some of the long-term problems seen in patients who develop Postconcussion syndrome (PCS). Since several if not all imaging modalities employed in TBI diagnosis are dependent on structural of functional rearrangement of cellular or extracellular components or assessment of blood-brain barrier (BBB) disruption, it is not surprising that surrogate peripheral or central nervous system (CNS) correlates of CT or MRI have been 6:Brain Stem StrokeA stroke occurs when blood supply to the brain is interrupted. The way a stroke affects the brain depends on which part of the brain suffers damage. Brain stem strokes can have complex symptoms, and they can be difficult to diagnose. Brain stem strokes can have complex symptoms, and they can be difficult to diagnose. If a stroke in the brain stem results from a clot, the faster blood flow can be restored in this critical area, the better the chances for recovery. The risk factors for brain stem stroke are the same as for stroke in other areas of the brain: high blood pressure, diabetes, heart disease, atrial fibrillation and smoking. Like strokes in other areas of the brain, brain stem strokes can be caused by a clot or a hemorrhage. There are also rare causes, like injury to an artery due to sudden head or neck movementsTrack 7:Neurodegenerative Diseases and ManagementNeurodegeneration is the progressive loss of structure or function of neurons, including death of neurons. Many neurodegenerative diseases occur as a result of neurodegenerative processes. Such diseases are incurable, resulting in progressive degeneration and/or death of neuron cells. As research progresses, many similarities appear that relate these diseases to one another on a sub-cellular level. Discovering these similarities offers hope for therapeutic advances that could ameliorate many diseases simultaneously. There are many parallels between different neurodegenerative disorders including atypical protein assemblies as well as induced cell death. Neurodegeneration can be found in many different levels of neuronal circuitry ranging from molecular to 8:Brain Stimulation TherapiesBrain stimulation therapies can play a role in treating certain mental disorders. Brain stimulation therapies involve activating or inhibiting the brain directly with electricity. The electricity can be given directly by electrodes implanted in the brain, or noninvasively through electrodes placed on the scalp. The electricity can also be induced by using magnetic fields applied to the head. While these types of therapies are less frequently used than medication and psychotherapies, they hold promise for treating certain mental disorders that do not respond to other treatmentsTrack 9:Alzheimer’s Disease & DementiaAlzheimer’s is one of the most common cause of dementia among older adults. Dementia is the loss of cognitive functioning, thinking, remembering, and reasoning and behavioural abilities to such an extent that it interferes with a person daily life and activities. Alzheimer's disease is currently ranked as the sixth leading cause of death in the United States. The causes of dementia can vary, depending on the types of brain changes that may be taking place. Other dementias include Lewy body dementia, frontotemporal disorders, and vascular dementia. It is common for people to have mixed dementia a combination of two or more disorders, at least one of which is dementia. Alzheimer's disease is a chronic neurodegenerative disease that usually starts slowly and worsens over time which is caused by 60–70% of cases of 10:Neurosurgery and Central Nervous SystemThe central nervous system is the part of the nervous system consisting of the brain and spinal cord. The central nervous system is so named because it integrates information it receives from, and coordinates and influences the activity of, all parts of the bodies of bilaterally symmetric animals that consider the retina and the optic nerve as well as the olfactory nerves and olfactory epithelium as parts of the CNS, synapsing directly on brain tissue without intermediate ganglia. The CNS is contained within the dorsal body cavity, with the brain housed in the cranial cavity and the spinal cord in the spinal canal. In vertebrates, the brain is protected by the skull, while the spinal cord is protected by the vertebrae. The brain and spinal cord are both enclosed in the meninges in central nervous systems, the intraneuronal space is filled with a large amount of supporting non-nervous cells called neuroglial 11:Mental illnessMental health includes our emotional, psychological, and social well-being. It affects how we think, feel, and act. It also helps determine how we handle stress, relate to others, and make choices. Mental health is important at every stage of life, from childhood and adolescence through adulthood. Over the course of your life, if you experience mental health problems, your thinking, mood, and behaviour could be affected. Many factors contribute to mental health problems, including Biological factors, such as genes or brain chemistry, Life experiences, such as trauma or abuse, Family history of mental health problems. Mental health refers to our cognitive, behavioural, and emotional wellbeing - it is all about how we think, feel, and behave. The term 'mental health' is sometimes used to mean an absence of a mental disorderTrack 12:Mental Health TherapiesThe central nervous system is the part of the nervous system consisting of the brain and spinal cord. The central nervous system is so named because it integrates information it receives from, and coordinates and influences the activity of, all parts of the bodies of bilaterally symmetric animals that is. Many consider the retina and the optic nerve as well as the olfactory nerves and olfactory epithelium as parts of the CNS, synapsing directly on brain tissue without intermediate ganglia. The CNS is contained within the dorsal body cavity, with the brain housed in the cranial cavity and the spinal cord in the spinal canal. In vertebrates, the brain is protected by the skull, while the spinal cord is protected by the vertebrae. The brain and spinal cord are both enclosed in the meninges in central nervous systems, the intraneuronal space is filled with a large amount of supporting non-nervous cells called neuroglial cells. A Neurosurgery is a physician who specializes in the diagnosis and surgical treatment of disorders of the central and peripheral nervous system including congenital anomalies, trauma, tumours, vascular disorders, infections of the brain or spine, stroke, or degenerative diseases of the spine Track 13:Case ReportsClinical trials and also tending of the challenges on CNS and Neurology investigate and by taking a gander at the most lately preclinical what’s more clinical investigations. Clinical trial safety and evaluation, Improvement of clinical trial development ,Biomarkers implication in clinical trial, Clinical trial safety and evaluation ,Current challenges in translational CNS research,Improvment of clinical trial development, New approaches for the design of clinical trials, Case reports related to CNS disorders and Neurology, Remedies for CNS & Neurological Disorders. CNS Bio-markers, a chance to be they genetic traits, biochemical transforms or alterations previously, structural alternately practical features, would needed on assistance the mixed bag of neurological disorders and to identify the progression of these diseases
AGENDA 2018------------------------------------------2019 Upcoming Soon------------------------------------------Day 1 April 10, 2018 Conference Hall: Meeting Place 3 08:00-09:00 Registrations09:00-09:30 Opening CeremonyKeynote Forum09:35-10:20 Title: Spring break: A true story of hope and determinationSteven Benvenisti, Davis, Saperstein & Salomon, USA10:20-11:05 Title: Physical exercise ensures health and longevity in brain integrityTrevor Archer, University of Gothenburg, SwedenGroup PhotoNetworking and Refreshments Break 11:05-11:20 @ Pre-function AreaSessions: Brain Disorders | Development Disorders | Dementia | Central Nervous System Disorders |Peripheral NeuropathySession Chair: Thomas F Fiener, Institute for EEG-Neurofeedback, GermanySession Co-Chair: Steven Benvenisti, Davis, Saperstein & Salomon, USASession Introduction11:20-11:50 Title: Locating zones of motor points (MPs) using needle invasive stimulation method (NISM)Albert Karimov, Samara State Medical University, Russia11:50-12:20Title: Possible implications of a shunt surgery on a blind child’s academic and spatialorientations skills - a case reportWaleed E Jarjoura, The Arab-American University- Palestine, Israel12:20-12:50 Title: Paraneoplastic neurological case reportKhaled AlHourani, Al Khalidi Hospital & Medical Center, JordanLunch Break 12:50-13:40 @ The GallerySymposium13:40-16:10 Title: Clinical EEG-neuroimaging, EEG-biomarkers and neurofeedbackThomas F Feiner, Adrián Gaitán Fariñas, Lena Ehrhard, Institute for EEG-Neurofeedback, GermanyNetworking & Refreshments Break 16:10-16:25 @ Pre-function AreaSpecial Session16:25-17:20 Title: Disability evaluation: Disability or malingering?Anthony Lee, Harvard University, USAPanel DiscussionDay 2 April 11 , 2018Hall-Meeting Place 3Keynote Forum09:45-10:30Title: QEEG, sLORETA and neurofeedback in the diagnosis and treatment of emotional andcognitive disordersThomas F Feiner, Institute for EEG-Neurofeedback, GermanySessions: Brain Stroke| Spinal Cord Disorders | Psychiatric Disorders | Neuro inaging and Radiology| BrainMappingSession Chair: Trevor Archer, University of Gothenburg, SwedenSession Co-Chair: Reza Amani, Isfahan University of Medical Sciences, IranSession Introduction10:30-11:00Title: Q-EEG analysis as foundation for neurofeedback treatments on the neurologicallydisordered patientsLena Ehrhard, Institute for EEG-Neurofeedback Munich, GermanyNetworking & Refreshments Break 11:00-11:15 @ Pre-function AreaPage 311:15-11:45Title: sLORETA neurofeedback in the cognitive remediation of brain insults: Recovering from analexia due to strokeAdrián Gaitán Fariñas, IFEN institute for EEG Neurofeedback, Germany11:45- 12:15 Title: Quality of life post strokeHashim Hasan Balubaid, King Saud Bin Abdulazizz University for Health Sciences, KSA12:15-12:45Title: Management of severe head injury and rule of intracranial pressure monitoring todecrease the morbidity and mortalityRaed Mohammad Odeh Aljubour, King Hussien Medical Center, JordanLunch Break 12:45-13:35 @ The Gallery13:35-14:05Title: Vitamin D levels and body antioxidant status in ischemic stroke patients: A case-controlstudyReza Amani, Isfahan University of Medical Sciences, Iran14:05-14:35 Title: Biochemical processes in penumbra after photothrombotic stroke in the rat cerebral cortexAnatoly Uzdensky, Southern Federal University, RussiaWorkshop14:35-15:35 Title:The spinal exam part 1: Lumbo-sacralAnthony Lee, Harvard University, USANetworking & Refreshments Break 15:35-15:50 @ Pre-function AreaPoster Judge: Thomas F Fiener, Institute for EEG-Neurofeedback, GermanyPoster Presentations 15:50-16:20BI-01 Title: Tobacco abuse worsening outcome in neuromyelitis opticaAshnaa Rao, Johns Hopkins University, USABI-02Title: Novel lignan derivatives from the twigs of Cinnamomum cassia and their potentialneuroprotective effectsJing Fu, Macau University of Science and Technology, ChinaBI-03 Title: Effects of nesfatin-1 on rat model of Parkinson’s disease induced by 6-hydroxydopamineDamla Anil, Marmara University, TurkeyPanel DiscussionDay 3 April 12 , 2018Hall-Meeting Place 3Keynote Forum10:00-10:45 Title: Structural and functional MRI correlates of post-stroke depressionWai K Wong Tang, Chinese University of Hong Kong, ChinaNetworking & Refreshments Break 10:45-11:00 @ Pre-function AreaWorkshop11:00-11:50 Title: The spinal exam part 2: cervico-thoracicAnthony Lee, Harvard University, USASessions: Neurosurgery | Neuropharmacology |Neuropathology | Brain Injury | NeurotherapeuticsSession Chair: Anthony Lee, Harvard University, USASession Introduction11:50-12:20 Title: Control of agitation among demented patientsHashim Hasan Balubaid, King Saud Bin Abdulazizz University for Health Sciences, KSA12:20-12:50Title: Epidemiological analysis of severe traumatic brain injuries managed at a surgicalintensive care unitAurélien Ndoumbe, University of Douala, CameroonVideo Presentation12:50-13:00 Title: Predicting neurological outcome and survival following cardiac arrestSanjay Deshpande, South Tyneside NHS FT, UKLunch Break 13:00-14:00 @ The GalleryPanel DiscussionAward & Closing Ceremony
Please contact the event manager Marilyn ( ) below for:- Multiple participant discounts- Price quotations or visa invitation letters- Payment by alternate channels (PayPal, check, Western Union, wire transfers etc)- Event sponsorshipNO REFUNDS ALLOWED ON REGISTRATIONSPrices may go up any time. Service fees included in pricing.-----------------------------------------------------------------This event is brought to you by:Conference Series - NewYorkEventsListhttp://
VIO181022CRE